Guidance for Industry on the Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications; Availability

Health and Human Services Department; Food and Drug Administration · 2011

Read Guidance for Industry on the Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications; Availability by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-11102.txt.

Description

Notice published in the Federal Register on 2011-05-06 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [Pages 26307-26308] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-11102] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0126] Guidance for Industry on the Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications; Availability AGENCY:.

Catalog record

CREATORHealth and Human Services Department; Food and Drug Administration
YEAR2011
COLLECTIONLAW
FORMATTXT
FILE SIZE6 KB
VERSION1.0
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEFederal Register

Source: https://www.federalregister.gov/documents/2011/05/06/2011-11102/guidance-for-industry-on-the-submission-of-summary-bioequivalence-data-for-abbreviated-new-drug

Browse the full library · About the Tower of Babel